GELATIN MEDICAL USE

Brand Owner Address Description
BEMATRIX NITTA GELATIN INC. 4-26, Sakuragawa 4-chome Naniwa-ku Osaka-shi Osaka 55-0022 Japan Gelatin for medical use, namely, used as hemostat agent; collagen for medical use, namely, used as hemostat agent; gelatin in the form of liquid, sol, gel or powder for medical use, namely, for making artificial blood vessels; collagen in the form of liquid, sol, gel or powder for medical use, namely, for making artificial blood vessels; gelatin in the form of liquid, sol, gel or powder for regenerating body tissue; collagen in the form of liquid, sol, gel or powder for regenerating body tissue; diagnostic reagents for medical use; microbial culture media for medical use; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; gelatin as an ingredient for pharmaceuticals as a carrier involved in the transportation of drugs and growth factors; collagen as an ingredient for pharmaceuticals as a carrier involved in the transportation of drugs and growth factors; materials for dental fillings and for sealing purposes;BE MATRIX;Chemical reagents for non-medical purposes, namely, chemical reagents for scientific and research purposes other than for medical or veterinary purposes; culture media for cultivating microbial cells for scientific and research purposes other than for medical or veterinary purposes; chemicals for use in industry; protein in the nature of gelatin in the form of liquid, sol, gel or powder for industrial use; protein in the nature of collagen in the form of liquid, sol, gel or powder for industrial use;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to compositions suitable for plasma substitution comprising as a plasma expander a recombinant gelatin-like protein. Characteristic is that the gelatin-like protein can be a monomer or a polymer like a dimer, trimer or a tetramer of a human recombinant gelatin-like protein having an isolectric point of less than 8. The resulting gelatin-like proteins provide a method to control the clearance rate of a plasma expander by its molecular weight. Preferably the gelatin-like proteins have a low hydroxyproline content which prevents the composition from gelling and thus allows the use of high-molecular weight proteins in order to establish a suitable colloid osmotic pressure. An additional advantage of the gelatin-like proteins is that these avoid the risk of anaphylactic shock that exists in conjunction with the use of commercially available preparations.